High Absorption CoQ10 200 mg with BioPerine

High Absorption CoQ10 200 mg with BioPerine

Doctor's Best4.8 (13,846 ratings)
Format:Capsule Quantity: 60 Veggie Cap(s) · 60 servings
Goals
$18.99 $0.31 per serving
WalmartLowest$18.99iHerb$19.99Vitacost$21.97Pure Formulas$37.17

Product analysis

75 out of 100

High Absorption CoQ10 200 mg with BioPerine offers reasonably priced CoQ10 for normal energy production, with limited evidence for easing fatigue. Added black-pepper extract may improve absorption, although a greater fatigue benefit remains uncertain.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

CoQ10 and its black-pepper ingredient are clearly identified. The size of any absorption advantage remains uncertain.

Ingredient Transparency100

Both ingredient amounts and forms are clearly stated. That makes the formula straightforward to check and compare.

Value For Money88

CoQ10 offers favorable value for the amount provided. The black-pepper ingredient’s separate value remains uncertain.

Customer Satisfaction93

Customer ratings are strongly favorable across a substantial number of reviews. They describe satisfaction rather than establish health benefits.

Product Focus79

CoQ10 fits cellular energy support and has limited evidence for fatigue and selected heart-health measures. Greater absorption from the companion ingredient does not establish greater benefit for all these goals.

Format
Capsule
Container
60 Veggie Cap(s)
Per serving
$0.31
Customer rating
4.8 · 13,846 ratings
Report analysis

Goals

Energy
Energy
Impact
Highest effect
A Ingredient FitD+ PathwaysB+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 in the declared ubiquinone form has limited evidence for fatigue relief and a role in cellular energy production. Its 200 mg serving reaches the saved preparation comparison. Piperine is included as an absorption partner, but this does not establish a greater fatigue benefit or an immediate alertness effect. Clinical disease results do not transfer automatically to healthy adults.

How this product is rated for Energy

Ingredient fit93

Coenzyme Q-10 anchors this product’s saved energy connection. The declared amounts reach the saved comparison levels; this does not make them validated fatigue-treatment doses.
Goal fit
Coenzyme Q-10 is the focused ingredient in the saved energy findings.
Dose adequacy
The declared amounts reach the saved comparison levels; this does not make them validated fatigue-treatment doses.

Pathways53

The saved findings concentrate on mitochondrial energy production, without establishing the size of a clinical benefit. That is a narrow connection rather than broad energy coverage.
Depth
The saved findings concentrate on mitochondrial energy production, without establishing the size of a clinical benefit.
Breadth
Coverage is concentrated in mitochondrial energy production, rather than extending across several distinct energy functions.

Evidence84

CoQ10 has limited preparation-specific support for fatigue relief.
Evidence strength
CoQ10 has limited preparation-specific support for fatigue relief.
Studied preparation
The preparation qualifies in the saved findings, although population and treatment limits still govern how its effects can be described.

Formulation logic100

No missing partner or specified conflict was identified. The included amounts meet the saved minimum comparisons, without establishing a routine energy benefit.
Partner coverage
Piperine is present as the identified CoQ10 absorption partner; this does not establish an added fatigue benefit.
Conflicts
No specified ingredient conflict was identified in the supplied findings.
Effective doses
The included ingredients meet the saved minimum amount comparisons; these are not proven fatigue-treatment thresholds.
Study evidence
Heart Health
Heart Health
Impact
Highest effect
A Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

Conventional CoQ10 has limited and mixed evidence for vascular, blood-pressure and lipid changes in selected adult populations. Its declared active serving amount supports the saved contribution without establishing the study’s duration or regimen. A generic CoQ10 declaration does not establish a redox form or a delivery advantage, and these findings do not establish prevention of cardiovascular events.

How this product is rated for Heart Health

Ingredient fit93

Coenzyme Q-10 anchors the relevant saved findings. Its declared amount meets the saved comparison.
Goal fit
Coenzyme Q-10 gives this formula a focused ingredient connection to heart-health markers, while its links to other goals reduce exclusive focus.
Dose adequacy
Coenzyme Q-10’s declared serving amount meets the saved comparison; this does not establish an optimal or clinically effective regimen.

Pathways60

The connection is concentrated in endothelial nitric-oxide function. Other heart-health processes have little or no coverage.
Depth
The strongest saved connection is to endothelial nitric-oxide function; this describes marker-related coverage rather than demonstrated prevention of heart disease.
Breadth
Coverage is concentrated in endothelial nitric-oxide function, with little or no coverage of the other evaluated heart-health processes.

Evidence98

CoQ10 leads the evidence finding, based on small, selected-population studies of vascular or blood-pressure markers.
Evidence strength
CoQ10 leads the evidence finding, based on small, selected-population studies of vascular or blood-pressure markers.
Studied preparation
The counted declarations meet the saved preparation comparison, without establishing finished-product equivalence or superiority of a particular delivery form.

Formulation logic100

No required partner is missing and none of the listed stimulant or high-sodium conditions applies. Counted ingredients meet the minimum amount comparison.
Partner coverage
No counted ingredient lacks a required partner under the supplied findings; this does not establish extra benefit from combining them.
Conflicts
The listed caffeine, stimulant and high-sodium conditions are not triggered by the supplied facts; this is a limited conflict check.
Effective doses
All counted ingredients meet the saved minimum amount comparison; excluded preparations and smaller contributions are not made effective by this finding.
Study evidence
Longevity
Longevity
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 supports cellular energy production and antioxidant recycling; piperine can increase circulating CoQ10, but increased absorption is not itself an aging outcome. The unidentified 200 mg preparation has less direct support than Q10Vital for selected skin findings, without evidence of lifespan extension.

How this product is rated for Longevity

Ingredient fit93

The saved assessment identifies 1 relevant ingredients and no other active ingredients; the formula serves 6 goals. The saved amount assessment is strong overall, with unknown amounts contributing no support.
Goal fit
The saved assessment identifies 1 relevant ingredients and no other active ingredients; the formula serves 6 goals.
Dose adequacy
The saved amount assessment is strong overall, with unknown amounts contributing no support.

Pathways40

Mitochondrial energy production is the strongest represented mechanism, with meaningful coverage in the saved findings. 1 of the three mechanism targets meets the saved coverage threshold.
Depth
Mitochondrial energy production is the strongest represented mechanism, with meaningful coverage in the saved findings.
Breadth
1 of the three mechanism targets meets the saved coverage threshold.

Evidence30

Coenzyme Q-10 leads the saved evidence comparison among ingredients meeting the amount threshold. This comparison does not imply uniform aging benefits. The saved evidence match is incomplete for Coenzyme Q-10.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison among ingredients meeting the amount threshold. This comparison does not imply uniform aging benefits.
Studied preparation
The saved evidence match is incomplete for Coenzyme Q-10.

Formulation logic100

The assessed ingredients work alone or have their required partner. No configured conflict was identified. 1 of 1 assessed ingredients meet the saved minimum amount threshold.
Partner coverage
The assessed ingredients work alone or have their required partner.
Conflicts
No configured conflict was identified.
Effective doses
1 of 1 assessed ingredients meet the saved minimum amount threshold.
Study evidence
Inflammation
Inflammation
Impact
High effect
B Ingredient FitD PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

CoQ10 in the ubiquinone form has limited evidence for lowering one inflammatory marker in statin-treated people with coronary artery disease. Other measured markers were unchanged, so this does not establish a broad clinical anti-inflammatory effect in general users. The 200 mg per serving is below the 300 mg daily study exposure; BioPerine does not establish an additional anti-inflammatory benefit.

How this product is rated for Inflammation

Ingredient fit80

Coenzyme Q-10 anchors the fit, with amount or preparation limits reducing the attributable contribution.
Goal fit
The declared ingredients are concentrated on the inflammation-related roles considered here.
Dose adequacy
The declared amount gives a partial contribution relative to the reviewed comparison exposures.

Pathways46

The represented contribution centres on oxidative and mitochondrial stress. Other specified routes have limited coverage.
Depth
Oxidative and mitochondrial stress is the strongest represented route, with ingredient-specific limits on the expected clinical effect.
Breadth
One specified route reaches the required coverage, with little breadth across the others.

Evidence93

Coenzyme Q-10 provides the strongest included finding. Biomarker or selected-population findings do not establish broad clinical benefit.
Evidence strength
Coenzyme Q-10 anchors the evidence finding, with the described population and biomarker limitations still applying.
Studied preparation
The included preparations satisfy the supplied comparison, without removing their population or outcome limitations.

Formulation logic100

The included ingredients meet the amount and partner checks, with no specified conflict triggered.
Partner coverage
No required supporting partner is missing for the included ingredients.
Conflicts
None of the specified ingredient conflict checks was triggered.
Effective doses
The included ingredients meet the minimum amount comparison; it is not a proven clinical anti-inflammatory dose.
Study evidence
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A Ingredient FitC PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

Coenzyme Q10 has limited evidence for changes in blood pressure, lipids and blood-vessel lining function in adults with dyslipidemia. The declared amount receives recognition, but preparation and population distinctions limit transfer to routine use. These marker findings do not establish fewer cardiovascular events, relief of statin symptoms or superiority of a particular form.

How this product is rated for Cardiovascular Support

Ingredient fit93

The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
The relevant ingredients dominate the formula, although the product may also be linked to other goals.
Dose adequacy
The ingredients included in this finding meet the saved amount criteria; this does not establish extra benefit from larger amounts.

Pathways60

The strongest recorded coverage concerns endothelial nitric-oxide function; this is a mechanism finding, not proof of fewer cardiovascular events.
Depth
The strongest recorded coverage concerns endothelial nitric-oxide function; this is a mechanism finding, not proof of fewer cardiovascular events.
Breadth
One cardiovascular mechanism reaches the coverage threshold, with limited coverage of the others.

Evidence88

Coenzyme Q-10 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
Coenzyme Q-10 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
The saved result accepts the relevant preparations, although this does not establish that the finished product matches a skin trial.

Formulation logic100

The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Study evidence
Metabolism Support
Metabolism Support
Impact
High effect
A Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 200 mg

Coenzyme Q10 participates in mitochondrial electron transport, helping cells carry out normal energy production. That role and changes in metabolic biomarkers do not establish that supplementation raises whole-body calorie expenditure. The declared amount is therefore a nutritional or mechanistic connection, without a demonstrated routine metabolism boost or preference for a particular form.

How this product is rated for Metabolism Support

Ingredient fit93

Coenzyme Q-10 provide the main connection. The included amounts meet the reference comparisons, but these are not proven thermogenic or weight-loss doses.
Goal fit
Coenzyme Q-10 provide the main metabolic connection, with little diversion to other ingredients.
Dose adequacy
The included amounts meet the reference comparisons, but these are not proven thermogenic or weight-loss doses.

Pathways54

The main connection concerns mitochondrial energy processes, which are not proof of increased whole-body calorie expenditure. The main coverage is concentrated in one area, rather than broad evidence for increased calorie expenditure.
Depth
The main connection concerns mitochondrial energy processes, which are not proof of increased whole-body calorie expenditure.
Breadth
The main coverage is concentrated in one area, rather than broad evidence for increased calorie expenditure.

Evidence75

CoQ10’s mitochondrial role and metabolic-marker findings do not establish a routine increase in whole-body energy expenditure.
Evidence strength
CoQ10’s mitochondrial role and metabolic-marker findings do not establish a routine increase in whole-body energy expenditure.
Studied preparation
The included preparations match the saved comparison, which does not establish a measured increase in energy expenditure.

Formulation logic100

No missing required partner or configured conflict was identified. The included amounts meet the minimum exposure comparison without demonstrating an extra benefit from combining them.
Partner coverage
No missing required partner was identified; the combination does not establish an additional metabolic-rate effect.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The included ingredients meet the minimum exposure comparison, which does not establish an effective thermogenic or weight-loss dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q10 (Ubiquinone)
 200 mg 81
Black Pepper ext. (Piperine)
 5 mg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
Coenzyme Q-10 (Ubiquinone) · 200 mg OverallScore81
C Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value
Each serving supplies 200 mg of CoQ10 as ubiquinone and includes BioPerine. The CoQ10 costs about $0.16 per 100 mg, a comparatively low price for this form.
How this ingredient is rated

Active Ingredient Quality & Bioavailability64

CoQ10 is ubiquinone and BioPerine is present as an absorption enhancer.
Molecular Form: Ubiquinol vs. Ubiquinone
The CoQ10 is ubiquinone, a form the body converts to ubiquinol.
Formulation & Absorption Enhancers
BioPerine is present as an absorption enhancer; its amount and effect on absorption are not established here.

Dose, Safety & Label Transparency88

The serving provides 200 mg of ubiquinone. A standard filler is also identified.
Clinical Dosage Alignment
The 200 mg of ubiquinone per serving aligns well with the evaluation.
Label Transparency & Fillers
The amount is stated, and the evaluation identifies a standard filler.

Value100

CoQ10 costs about $0.16 per 100 mg, a comparatively low price for ubiquinone.
Price Per Effective Serving
CoQ10 costs about $0.16 per 100 mg, a comparatively low price for ubiquinone.
View ingredientView products
87 Performance

Extra Strength Ubiquinol 200 mg

NOW
Reduced ubiquinol at 200 mg in a softgel combines a readily absorbed form with a substantial amount for targeted use. Compared with the original, it closely matches the original's listed 200 mg CoQ10 amount and uses reduced ubiquinol instead of the original's conventional or unspecified form, giving a well-specified option for the same CoQ10 goals.
85 Performance

Mega Ubiquinol CoQ10 100 mg

Qunol
Reduced ubiquinol at 100 mg in a softgel provides a clearly stated maintenance amount, while the small fat-soluble vitamin C addition contributes limited extra value. Compared with the original, it uses a lower listed CoQ10 amount than the original's 200 mg and uses reduced ubiquinol instead of the original's conventional or unspecified form, giving a well-specified option for the same CoQ10 goals.
87 Performance

QH-absorb 100 mg

Jarrow Formulas
Reduced ubiquinol at 100 mg provides a clearly stated maintenance amount, while CoQ10 may reduce warfarin's anticoagulant effect. Compared with the original, it uses a lower listed CoQ10 amount than the original's 200 mg and uses reduced ubiquinol instead of the original's conventional or unspecified form, giving a well-specified option for the same CoQ10 goals.
86 Budget

CoQ10 100 mg

Lake Avenue Nutrition
A clearly identified 100 mg ubiquinone amount offers focused CoQ10 support, though the dry capsule lacks a listed lipid carrier. Compared with the original, it uses a lower listed CoQ10 amount than the original's 200 mg and retains a conventional ubiquinone form, while lowering recurring cost.
85 Budget

High Absorption CoQ10 with BioPerine 100 mg

Doctor's Best
A 100 mg ubiquinone amount with 5 mg of piperine targets absorption, but the dry capsule lacks a lipid carrier and piperine may alter the handling of some medicines. Compared with the original, it uses a lower listed CoQ10 amount than the original's 200 mg and retains a conventional ubiquinone form, while lowering recurring cost.
84 Budget

CoQ10 100 mg

California Gold Nutrition
A 100 mg ubiquinone amount in a softgel supports uptake of the fat-soluble active, while CoQ10 may reduce warfarin's anticoagulant effect. Compared with the original, it uses a lower listed CoQ10 amount than the original's 200 mg and retains a conventional ubiquinone form, while lowering recurring cost.
84 Value

CoQ10 100 mg

Best Naturals
A 100 mg ubiquinone amount provides focused CoQ10 support, though the dry capsule has no stated lipid carrier and CoQ10 may reduce warfarin response. Compared with the original, it uses a lower listed CoQ10 amount than the original's 200 mg and retains a conventional ubiquinone form, while the lower recurring cost strengthens practical value.
83 Value

CoQ10 100 mg plus BioPerine

Lake Avenue Nutrition
A 100 mg ubiquinone amount in a softgel supports uptake, while 5 mg of black pepper extract may change exposure to some medicines. Compared with the original, it uses a lower listed CoQ10 amount than the original's 200 mg and retains a conventional ubiquinone form, while the lower recurring cost strengthens practical value.
82 Value

CoQ10 100 mg wtih BioPerine

California Gold Nutrition
A 100 mg ubiquinone amount with 5 mg of piperine offers a focused formula, but the dry capsule lacks a lipid carrier and piperine may alter medicine exposure. Compared with the original, it uses a lower listed CoQ10 amount than the original's 200 mg and retains a conventional ubiquinone form, while the lower recurring cost strengthens practical value.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10